Exchange: NYSEMkt·Updated 07:57 PM EDT
TOVX logo

TOVX Theriva Biologics Inc

$0.225
$0.0001
(0.04%)
Today
Closed $0.225
$0.0125
(5.56%)
After Hours
Reported EarningsAug 11
Mkt Cap$10.33M
Vol382,930.00

About TOVX

Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004. SYN-020 is intended to prevent the antibiotic-mediated microbiome damage, C. difficile infections (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR) and acute graft-versus-host disease (aGVHD) in allogeneic HCT recipients. SYN-004 is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antimicrobial resistance. The company was founded by Steven H. Kanzer on January 8, 2001 and is headquartered in Rockville, MD.
61

Bullish Sentiment

How do you feel about TOVX?

Lovelife68
$TOVX $ONCY Life saving treatments are being held from the public by these corrupt market makers and naked shorts. These absurd low valuations force these companies to toxic financing absolutely ridiculous.
3
Lovelife68
$TOVX Steven Shallcross has made millions in salary as ceo of Theriva Biologics. He has 45,000,000 million shares outstanding. 2 reverse splits stock price from 50.00 to .22 cents. Three months cash left for a company that is potentially worth billions he even has his wife on payroll. He is a disgrace!
3
dogood
$TOVX Theriva Biologics Announces Nature Medicine Publication Of Phase 2b VCN-01 Data In Metastatic Pancreatic Cancer Benzinga
3
Lovelife68
$TOVX VCN-01 has Orphan Drug Designation from both the FDA and EMA and Rare Pediatric Disease Designation from the FDA for the treatment of retinoblastoma. Plan to discuss the proposed clinical trial protocol with the FDA in Q3 2026. Did they pick the last day in September come on
2
Theo0107
$TOVX Since the analysts won't say it, I will: I'm upgrading the stock price target from $0.23 to $0.50.
2
Flazz72
$TOVX All 3 of my recent posts regarding Theriva lawsuit are not being posted. What's going on here?
1
VinnyLaw
$TOVX I have loved the science behind this company, but management has caused me concern. I’ve reached out to IR, but I doubt I’ll hear back. I’m really concerned about the long term prospects of this without management’s focus on increasing shareholder value.
1
Flazz72
$TOVX Yes tried 4 times now to give a link to lawsuit but the site will not post, any suggestions? Hello stocktwits management?
Flazz72
$TOVX Theres a lawsuit filed against Theriva Biologics who in their 8/24/26 planning a Reverse Merger- Order Wed 09/23 12:46 PM-MINUTE ORDER IN CHAMBERS of the Honorable District Judge Anne R. Traum on 9/23/2026. Re:2 Motion for TRO Responses are due by 9/29/2026 (no image attached) Plaintiff has filed an Emergency Motion for Temporary Restraining Order and/or Preliminary Injunction (ECF No. 2 ). Plaintiff's motion includes a declaration regarding the basis for expedited briefing and emergency relief pursuant to Local Rule 7-4. Having reviewed these declarations, the Court determines Plaintiff's motion warrants consideration on an expedited basis. IT IS HEREBY ORDERED that Plaintiff shall serve a copy of this Order and their emergency motion on Defendant by September 25, 2026 and file a Notice of Compliance with the court by September 25, 2026. IT IS HEREBY ORDERED that Defendant shall have until September 29, 2026 to file a response to Plaintiff's Motion for a Temporary Restraining
Chicagoteacher
$TOVX amazing that this company was founded in 1986 and has never gotten a product to market. Stock price has only fallen over time. We're all suckers like Charlie Brown hoping one day Lucy will let us kick the football.

Advertisement|Remove ads.